2.44% 0.0003

Vincerx Pharma Inc (VINC)

개요 뉴스 가격 이력 Financials 토론 예측

Relative Volume:

Vincerx Pharma Inc Stock (VINC) Company Profile

Vincerx Pharma Inc

Healthcare (1114)

Biotechnology (618)

최신 SEC 제출 서류

VINC's Discussions on Twitter

Compare VINC vs VRTX, REGN, ARGX, ALNY, ONC

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
VINC Vincerx Pharma Inc	0.0126	0	0	-48.85M	-46.25M	-2.31
VRTX Vertex Pharmaceuticals Inc	499.17	117.08B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	772.03	82.63B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	742.79	45.82B	4.16B	1.29B	734.26M	19.59
ALNY Alnylam Pharmaceuticals Inc	322.38	42.92B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	305.39	33.54B	5.36B	287.73M	924.18M	2.5229

Vincerx Pharma Inc Stock (VINC) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2022-01-14	개시	H.C. Wainwright	Buy
2021-12-23	개시	Cantor Fitzgerald	Overweight
2021-11-01	개시	SVB Leerink	Outperform
2021-09-13	개시	Laidlaw	Buy
2021-08-25	개시	B. Riley Securities	Buy

Vincerx Pharma Inc 주식(VINC)의 최신 뉴스

Vincerx Pharma Inc (VINC) 재무 분석

Vincerx Pharma Inc (VINC)

Vincerx Pharma Inc Stock (VINC) Company Profile

Compare VINC vs VRTX, REGN, ARGX, ALNY, ONC

Vincerx Pharma Inc Stock (VINC) Upgrades & Downgrades

Vincerx Pharma Inc 주식(VINC)의 최신 뉴스

VINC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Head to Head Comparison: Ampio Pharmaceuticals (NYSE:AMPE) & Vincerx Pharma (NASDAQ:VINC) - Defense World

Contrasting Vincerx Pharma (NASDAQ:VINC) and iBio (NYSE:IBIO) - Defense World

Critical Review: Vincerx Pharma (NASDAQ:VINC) & Trevena (NASDAQ:TRVN) - Defense World

Reviewing Leap Therapeutics (NASDAQ:LPTX) and Vincerx Pharma (NASDAQ:VINC) - Defense World

Analyzing Vincerx Pharma (NASDAQ:VINC) & Petros Pharmaceuticals (NASDAQ:PTPI) - Defense World

Head to Head Analysis: Vectura Group (OTCMKTS:VEGPF) and Vincerx Pharma (NASDAQ:VINC) - Defense World

Vincerx Pharma, Inc. (VINC) Stock forecasts - Yahoo

Analyzing Neoleukin Therapeutics (NASDAQ:NLTX) & Vincerx Pharma (NASDAQ:VINC) - Defense World

Vincerx Pharma, Inc. (VINC) stock price, news, quote and history - Yahoo

Vincerx Pharma, Inc.Common Stock (NQ: VINC - FinancialContent

Vincerx Pharma ends sales agreement, approves reverse stock split - MSN

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VINC, NEUE, ZUO on Behalf of Shareholders - ACCESS Newswire

Vincerx Pharma, Inc. Announces Additional Adjournment of - GlobeNewswire

Vincerx Pharma, Inc. Urges Stockholders to Vote FOR Approval of Dissolution Proposal and Announces Potential Range for Distributions to Stockholders - The Manila Times

Vincerx Pharma, Inc. Urges Stockholders to Vote FOR - GlobeNewswire

Vincerx Pharma, Inc. Announces Adjournment of Special MeetingWill Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution Proposal - Yahoo Finance

At a crossroads, biotechs are passing on reverse mergers in 2025 - Endpoints News

Global Digital Holdings Inc. cancelled the acquisition of Vincerx Pharma, Inc. in a reverse merger transaction. - marketscreener.com

VINC: Vincerx Pharma to dissolve, with minimal or no distributions expected for stockholders - TradingView

VINC Stock Price, News & Analysis - Stock Titan

VINC Stock Price and Chart — OTC:VINC - TradingView

VINC stock touches 52-week low at $0.17 amid sharp annual decline - Investing.com

Vincerx Pharma Announces Suspension and Intent to Delist Common Stock from Nasdaq - Nasdaq

vincerx pharma cancels merger, initiates wind-down activities - Investing.com

Vincerx's final merger attempt collapses, leaving ADC biotech to wind down - Fierce Biotech

Vincerx Pharma ends merger talks, begins asset wind-down - Investing.com

VINC Stock Plummets to 52-Week Low of $0.48 Amid Steep Decline - Investing.com

Vincerx Pharma Inc. (VINC) reports earnings - qz.com

Vincerx, left in limbo by collapsed deal, moves to merge with AI company to escape cash crisis - Fierce Biotech

Finance Watch: Sutro Halves Workforce, Cuts Lead ADC And CEO Moves On - insights.citeline.com

Cash-strapped Vincerx left mulling future after Oqory reverse merger falls apart - Fierce Biotech

Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives - Yahoo Finance

Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqory’s TROP2 Antibody Drug Conjugate, OQY-3258 - Yahoo Finance

Vincerx Pharma, Inc. Announces 1-for-20 Reverse Stock Split Effective January 27, 2025 - Nasdaq

Palo Alto's Vincerx Pharma plans reverse stock split amid merger plans - The Business Journals

Vincerx Pharma, Inc. Announces Reverse Stock Split - GlobeNewswire

Vincerx Pharma enters at-the-market equity offering deal - Investing.com

Kahn Swick & Foti, LLC Investigates Merger of Vincerx Pharma, Inc.VINC | FinancialContent - FinancialContent

Vincerx acquisition leads to C-suite shake-up—Chutes & Ladders - Fierce Biotech

Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers - Fierce Biotech

Vincerx Pharma Stock Rises On Proposed Merger With Oqory: Retail Remains Bullish - Asianet Newsable

Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc. - Yahoo Finance

Vincerx Pharma Stock Gets Retail Followers Buzzing With Big Layoff Plans To Sustain Cancer Drug Trials - Stocktwits

Vincerx Pharma Inc (VINC) Quarterly 10-Q Report - qz.com

What Makes Vincerx Pharma (VINC) a New Buy Stock - Yahoo Finance

VINC Stock Touches 52-Week Low at $0.51 Amid Market Challenges - Investing.com

Vincerx reports two complete responses in VIP943 study By Investing.com - Investing.com UK

Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants - Investing News Network

Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants - Investing News Network

Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - Investing News Network

Vincerx Pharma Inc (VINC) 재무 분석

매출

순이익

현금흐름

주당 순 이익

VINC과 유사한 종목